Having received infliximab in the past

Having a history of serious infection which caused hospitalization within 6 months before the registration

Having an active tuberculosis

Having a complication or a history of malignancy within 5 years before the registration

Efficacy and Safety of Increased Dose of TA-650(Infliximab) in Patients With Rheumatoid Arthritis